Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 19Neoplasms 12Colorectal Neoplasms 5Pain, Postoperative 4Fatigue 4Thyroid Neoplasms 3Stomatitis 3Pain 3Malnutrition 3Liver Neoplasms 3Depression 3Carcinoma, Hepatocellular 3Anxiety Disorders 3Stomach Neoplasms 2Sleep Initiation and Maintenance Disorders 2Polycystic Ovary Syndrome 2Parasomnias 2Motor Activity 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Breast Cancer Female 2Agnosia 2Weight Loss 1Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Incontinence 1Unilateral U/S PVB 1Ulcer 1

Interventions

Cisplatin 72Brachytherapy 31Radiotherapy 26Paclitaxel 23Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21human papillomavirus vaccine, L1 type 16, 18 20Topotecan 18Papillomavirus Vaccines 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 16pembrolizumab 14Radiation 12Gemcitabine 12Early Intervention, Educational 12Colposcopy 12Methods 11Magnetic Resonance Spectroscopy 11atezolizumab 10Radiotherapy, Intensity-Modulated 10Blood Specimen Collection 10Papanicolaou Test 9Docetaxel 9Vaccines, Synthetic 8Platinum 8Nivolumab 8Ipilimumab 8Counseling 81,2-diaminocyclohexaneplatinum II citrate 8Vaccines 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Neoplasms × Control Groups × Clear all
NCT05149248 2021-12-08

CONDESA

Instituto Nacional de Salud Publica, Mexico

Phase 2/3 Completed
6,000 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡